Leica BOND-III Wins 2011 Medical Design Excellence Award
Leica BOND-III wins 2011 MDEA
Innovative design that provides results 50% faster than previous-generation instruments
Melbourne, Australia. The Leica BOND-III instrument, a fully automated immunohistochemistry (IHC) and in situ hybridization (ISH) staining system used in cancer and infectious diseases diagnosis, has been awarded the prestigious Medical Design Excellence Award (MDEA) for its innovative design that provides results 50% faster than previous-generation instruments.
The MDEA competition is the premier worldwide awards program for the medical technology community. It recognizes the achievements of medical device manufacturers and suppliers who are responsible for creating innovative products that are changing the face of healthcare.
Leica BOND-III uses unique automation systems and advanced software to significantly reduce protocol run times, achieve high throughput and improve laboratory efficiency. Together, these advances help laboratories deliver critical results sooner and at lower costs. Chris Rhoades, Global Product Manager for Leica BOND Systems said, “Waiting for test results can be stressful for patients. By reducing this time, the Leica BOND-III instrument reduces the anxiety of patients and their families, and enables quicker access to the correct treatment for life threatening diseases.”
Designed for Lean Histology, the Leica BOND-III instrument helps diagnostic laboratories facing increased pressure to process greater numbers of patient samples with no corresponding budget or staff increases. The labor savings afforded by Leica BOND-III automation free technicians to perform other tasks while decreased run times allow additional tests to be performed each day. Leica BOND-III further improves laboratory operation by reducing maintenance, waste disposal costs and environmental impact. Also, by providing the ideal mix of scheduling flexibility and case organization, the system’s unique three-tray continuous processing capability helps optimize laboratory workflow. Combined, these benefits help laboratories meet increasing workloads using existing resources while both saving time and reducing costs.
The MDEA will be officially presented in a ceremony at the Medical Design & Manufacturing East 2011 Conference and Exposition in New York in June 2011. Representatives from Leica Microsystems and their design partner Invetech will be present to receive the award.
Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.
Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.
Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.
The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.